Antieosinophilic activity of orazipone

Molecular Pharmacology

Volumn 69, Issue 6, 2006, Pages 1861-1870

  Kankaanranta, Hannu ^a,c   Ilmarinen, Pinja ^a   Zhang, Xianzhi ^a,b   Nissinen, Erkki ^d   Moilanen, Eeva ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b INSTITUTE OF BIOPHYSICS   (China)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d ORION CORPORATION   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 CHLORO 3 NITRO BENZYLIDENE) PENTANE 2,4 DIONE; CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; DNA FRAGMENT; FAS ANTIGEN; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; OR 2370; ORAZIPONE; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME INDUCTION; ENZYME INHIBITION; EOSINOPHIL; GRANULOCYTE; HUMAN; HUMAN CELL; LIGATION; NECROSIS; NEUTROPHIL; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; BENZYLIDENE COMPOUNDS; CASPASES; DNA FRAGMENTATION; EOSINOPHILS; HUMANS; INTERLEUKIN-5; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KETONES; NEUTROPHILS; SULFHYDRYL COMPOUNDS;

EID: 33745173850     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.021170     Document Type: Article

References (37)

1. Adachi T, Motojima S, Hirata A, Fukuda T, Kihara N, Kosaku A, Ohtake H, and Makino S (1996) Eosinophil apoptosis caused by theophylline, glucocorticoids and macrolides after stimulation with IL-5. J Allergy Clin Immunol 98:S207-S215.
2. Aho P, Bäckström R, Koponen A, Linden I-B, Lotta T, Lönnberg K, Pippuri A, and Pohto P (2001), inventors; OrionPharma, assignee. Substituted β diketones and their use. U.S. patent 6,201,027. 2001 March 13.
3. Bonny C, Oberson A, Negri S, Sauser C, and Schorderet DF (2001) Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50:77-82.
4. Daigle I and Simon HU (2001) Critical role for caspases 3 and 8 in neutrophil but not eosinophil apoptosis. Int Arch Allergy Immunol 126:147-156.
5. De Souza PM, Kankaanranta H, Michael A, Barnes PJ, Giembycz MA, and Lindsay MA (2002) Caspase-catalyzed cleavage and activation of Mst1 correlates with eosinophil but not neutrophil apoptosis. Blood 99:3432-3438.
6. Dewson G, Cohen GM, and Wardlaw AJ (2001) Interleukin-5 inhibits translocation of Bax to the mitochondria, cytochrome c release and activation of caspases in human eosinophils. Blood 98:2239-2247.
7. Druilhe A, Letuve S, and Pretolani M (2003) Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 8:481-495.
8. Gardai SJ, Hoontrakoon R, Goddard CD, Day BJ, Chang LY, Henson PM, and Bratton DL (2003) Oxidant-mediated mitochondrial injury in eosinophil apoptosis: enhancement by glucocorticoids and inhibition by granulocyte-macrophage colony-stimulating factor. J Immunol 170:556-566.
9. Giembycz MA and Lindsay MA (1999) Pharmacology of the eosinophil. Pharmacol Rev 51:213-340.
10. Gleich GJ (2000) Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105:651-663.
11. Hagan JB, Kita H, and Gleich GJ (1998) Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids. Clin Exp Allergy 28:999-1006.
12. Hall DJ, Cui J, Bates ME, Stout BA, Koenderman L, Coffer PJ, and Bertics PJ (2001) Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability. Blood 98:2014-2021.
13. Hebestreit H, Dibbert B, Balatti I, Braun D, Schapowal A, Blaser K, and Simon HU (1998) Disruption of fas receptor signaling by nitric oxide in eosinophils. J Exp Med 187:415-425.
14. Kankaanranta H, De Souza PM, Barnes PJ, Salmon M, Giembycz MA, and Lindsay MA (1999) SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils. J Pharmacol Exp Ther 290:621-628.
15. Kankaanranta H, Lindsay MA, Giembycz MA, Zhang X, Moilanen E, and Barnes PJ (2000a) Delayed eosinophil apoptosis in asthma. J Allergy Clin Immunol 106:77-83.
16. Kankaanranta H, De Souza PM, Giembycz MA, and Lindsay MA (2000b) Human eosinophil isolation and the measurement of apoptosis in asthma: mechanisms and protocols (Chung KF and Adcock IM eds) pp 99-110, Humana Press Inc., Totowa.
17. Kankaanranta H, Giembycz MA, Barnes PJ, Haddad E-B, Saarelainen S, Zhang X, Moilanen E, and Lindsay MA (2002) Hydrogen peroxide reverses IL-5-afforded eosinophil survival and promotes constitutive human eosinophil apoptosis. Int Arch Allergy Immunol 127:73-78.
18. Kankaanranta H, Moilanen E, and Zhang X (2005) Pharmacological regulation of human eosinophil apoptosis. Curr Drug Targets Inflamm Allergy 4:433-445.
19. Lin A and Dibling B (2002) The true face of JNK activation in apoptosis. Aging Cell 1:112-116.
20. Manning AM and Davis RJ (2003) Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2:554-565.
21. Miike S, Nakao A, Hiraguri M, Kurasawa K, Saito Y, and Iwamoto I (1999) Involvement of JAK2, but not PI3-kinase/Akt and MAP kinase pathways, in anti-apoptotic signals of GM-CSF in human eosinophils. J Leukoc Biol 65:700-706.
22. Nissinen E, Serkkola E, Penttilä KE, Kaivola J, and Linden I-B (1997) Suppression of cytokine production and neutrophil activation by an immunomodulating agent OR-1384 (Abstract). Gastroenterology 112:A1051.
23. Nissinen E, Kaivola J, and Linden I-B (1998) Inhibition of neutrophil activation by a novel thiol modulating compound OR-1384 (Abstract). Naunyn-Schmiedeberg's Arch Pharmacol 358 (Suppl 2):R668.
24. Ruotsalainen M, Koponen A, Nissinen E, and Hyttilä M (2000) Efficacy of a new anti-inflammatory compound, orazipone, in the models of airway eosinophilia in rat and guinea pigs (Abstract). Eur Respir J 16 (Suppl 31):s560.
25. Schwartz RS (2003) The hypereosinophilic syndrome and the biology of cancer. N Engl J Med 348:1199-1200.
26. Serkkola E and Nissinen E (1999) The effect of orazipone on LPS-induced IL-1β and TNFα production (Abstract). Med Inflammation 8:S84.
27. Vendelin J, Laitinen C, Vainio P, Nissinen E, Mäki T, and Eklund KK (2005) The novel sulfhydryl-reactive compounds orazipone and OR-1958 inhibit cytokine production in rat and human (HMC-1) mast cells. Int Immunopharmacol 5:177-184.
28. Vignola AM, Chanez P, Chiappara G, Siena L, Merendino A, and Reina C (1999) Evaluation of apoptosis of eosinophils, macrophages and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol 103:563-573.
29. Walker A, Ward C, Dransfield I, Haslett C, and Rossi AG (2003) Regulation of granulocyte apoptosis by hemopoietic growth factors, cytokines and drugs: potential relevance to allergic inflammation. Curr Drug Targets Inflamm Allergy 2:339-347.
30. Walsh GM, Sexton DW, and Blaylock MG (2003) Mechanisms of steroid action and resistance in inflammation: corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma. J Endocrinol 178:37-43.
31. Wedi B, Raap U, Lewrick H, and Kapp A (1997) Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J Allergy Clin Immunol 100:536-543.
32. Wedi B, Straede J, Wieland B, and Kapp A (1999) Eosinophil apoptosis is mediated by stimulators of cellular oxidative metabolisms and inhibited by antioxidants: involvement of a thiol-sensitive redox regulation in eosinophil death. Blood 94:2365-2373.
33. Wrobleski T, Graul A, and Castaner J (1998) Orazipone. Drugs Future 23:28-31.
34. Zangrilli J, Robertson N, Shetty A, Wu J, Hastie A, Fish JE, Litwack G, and Peters SP (2000) Effect of IL-5, glucocorticoid and Fas ligation on Bcl-2 homologue expression and caspase activation in circulating human eosinophils. Clin Exp Immunol 120:12-21.
35. Zhang X, Moilanen E, Adcock IM, Lindsay MA, and Kankaanranta H (2002) Divergent effect of mometasone on human eosinophil and neutrophil apoptosis. Life Sci 71:1523-1534.
36. Zhang X, Moilanen E, and Kankaanranta H (2000) Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide and beclomethasone. Eur J Pharmacol 406:325-332.
37. Zhang X, Moilanen E, Lahti A, Hamalainen M, Giembycz MA, Barnes PJ, Lindsay MA, and Kankaanranta H (2003) Regulation of eosinophil apoptosis by nitric oxide: role of c-jun-N-terminal kinase and signal transducer and activator of transcription 5. J Allergy Clin Immunol 112:93-101.